Emergent BioSolutions Inc.EBSNYSE
Loading
Total debt minus cash and cash equivalents
3Y CAGR
-22.4%/yr
vs +3.5%/yr prior
5Y CAGR
+4.0%/yr
Recent deceleration
Acceleration
-25.9pp
Decelerating
Percentile
P64
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
3 yr
Consecutive declineNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $366.70M | -36.4% |
| 2024 | $576.60M | -23.0% |
| 2023 | $748.50M | -4.5% |
| 2022 | $783.80M | +166.0% |
| 2021 | $294.70M | -2.3% |
| 2020 | $301.70M | -54.9% |
| 2019 | $668.90M | -2.0% |
| 2018 | $682.40M | +514.0% |
| 2017 | $-164.84M | -4721.1% |
| 2016 | $-3.42M | - |